SCHEMBL7928277

SCHEMBL7928277

N#Cc1cccc(-c2ccc(CCC(CCCc3ccc(-c4ccccc4)cc3)C(=O)O)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.64
MMP13 P45452 2/20 0.64
FOLH1 Q04609 1/20 0.51
MME P08473 1/20 0.47
MMP2 P08253 2/20 0.46
MMP3 P08254 2/20 0.46
FAAH O00519 1/20 0.45
XDH P47989 1/20 0.45
SLC22A12 Q96S37 1/20 0.45
ADAMTS4 O75173 1/20 0.44
FDFT1 P37268 2/20 0.44
FFAR1 O14842 1/20 0.43
C3AR1 Q16581 1/20 0.43
GRIK1 P39086 1/20 0.43
PTPN5 P54829 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7932591 0.99 MMP12 (0.63) MMP12MMP13FOLH1MMEMMP2
SCHEMBL3467249 0.91 MMP12 (0.54) MMP12MMP13FOLH1MMP2MMP3
SCHEMBL7917889 0.90 MMP12 (0.55) MMP12MMP13FOLH1MMEMMP2
SCHEMBL7924636 0.89 MMP12 (0.65) MMP12MMP13FOLH1MMEMMP2
SCHEMBL7928937 0.89 MMP12 (0.54) MMP12MMP13FOLH1MMP2MMP3
SCHEMBL7922593 0.88 MMP12 (0.56) MMP12MMP13FOLH1MMEMMP2
SCHEMBL3467248 0.87 MMP13 (0.51) MMP12MMP13MMP2MMP3ADAMTS4
SCHEMBL3467017 0.87 MMP12 (0.57) MMP12MMP13FOLH1MMEMMP2
SCHEMBL1861903 0.83 GRIK1 (0.59) MMP12MMP13MMEMMP2MMP3
SCHEMBL3467200 0.83 MMP12 (0.60) MMP12MMP13FOLH1MMEMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed